BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7782031)

  • 1. Recombinant a2 interferon (a-IFN) with chemo-hormonal therapy in patients with hepatocellular carcinoma (HCC).
    Kountouras J; Boura P; Karolides A; Zaharioudaki E; Tsapas G
    Hepatogastroenterology; 1995 Feb; 42(1):31-6. PubMed ID: 7782031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma.
    Cheng AL; Yeh KH; Fine RL; Chuang SE; Yang CH; Wang LH; Chen DS
    Hepatogastroenterology; 1998; 45(24):1955-60. PubMed ID: 9951847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
    Lu YS; Hsu C; Li CC; Kuo SH; Yeh KH; Yang CH; Hsu CH; Wu CY; Cheng AL
    Hepatogastroenterology; 2004; 51(57):815-9. PubMed ID: 15143923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial.
    Lai CL; Lau JY; Wu PC; Ngan H; Chung HT; Mitchell SJ; Corbett TJ; Chow AW; Lin HJ
    Hepatology; 1993 Mar; 17(3):389-94. PubMed ID: 8383088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinoma.
    Bokemeyer C; Kynast B; Harstrick A; Laage E; Schmoll E; von Wussow P; Schmoll HJ
    Cancer Chemother Pharmacol; 1995; 35(4):334-8. PubMed ID: 7828277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled clinical trial of doxorubicin and tamoxifen versus doxorubicin alone in hepatocellular carcinoma.
    Melia WM; Johnson PJ; Williams R
    Cancer Treat Rep; 1987 Dec; 71(12):1213-6. PubMed ID: 2446752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M; Kobayashi Y; Urawa N; Yamamoto M; Mifuji R; Araki J; Tanaka H; Horiike S; Itani T; Furjita N; Konishi M; Iwasa M; Kaito M; Adachi Y
    Hepatogastroenterology; 2007 Mar; 54(74):518-21. PubMed ID: 17523311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy for hepatocellular carcinoma].
    Okusaka T; Ueno H; Ikeda M
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2122-8. PubMed ID: 15628756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
    Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplenic and transtumoral in vivo immunostimulation: effect on cellular immunity parameters.
    Boura P; Kountouras J; Lygidakis NJ; Safioleas M; Aphinives P
    Hepatogastroenterology; 1999; 46(26):799-803. PubMed ID: 10370616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemotherapy with recombinant interleukin-2 and adriamycin in primary hepatocellular carcinoma.
    Chien CH; Hsieh KH; Yang PM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 May; 24(2):201-12. PubMed ID: 1649735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinoma.
    Creagan ET; Long HJ; Frytak S; Moertel CG
    Cancer; 1988 Jan; 61(1):19-22. PubMed ID: 2825959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors.
    Lin SM; Lin CJ; Hsu CW; Tai DI; Sheen IS; Lin DY; Liaw YF
    Cancer; 2004 Jan; 100(2):376-82. PubMed ID: 14716774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial.
    Lai CL; Wu PC; Lok AS; Lin HJ; Ngan H; Lau JY; Chung HT; Ng MM; Yeoh EK; Arnold M
    Br J Cancer; 1989 Dec; 60(6):928-33. PubMed ID: 2557881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis].
    Nakamura Y; Kawaguchi M; Hata A; Watanabe H; Ueki Y; Oribe T; Koba F; Takamuku K
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatocellular carcinoma treated by intraarterial injection of adriamycin/mitomycin C oil suspension alone or combined with cis-diaminodichloroplatinum].
    Inoue H; Miyazono N; Hori A; Kanetsuki I; Tanaka D; Fukukura Y; Tsuchimochi S; Hokotate H; Ida K; Ikeda K
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1049-53. PubMed ID: 8390227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma].
    Zhou QM; Wu PH; Zhao M; Wang QJ; Huang LX; Li YQ; Chen SP; Xia JC
    Ai Zheng; 2006 Nov; 25(11):1414-8. PubMed ID: 17094912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemoembolization and regional hyperthermia with degradable starch microspheres in the treatment of malignant hepatic tumors].
    Yoshikawa T; Oyamada H; Itani K; Tainaka K; Seto O; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2646-52. PubMed ID: 2843131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.